Beta-blockade in Unruptured Intracranial Aneurysm

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT06249802

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06249802
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06249802. Randomized; quadruple masking; primary purpose prevention. Start 2025-01-01 (anticipated); primary completion 2029-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Beta-blockade in Unruptured Intracranial Aneurysm
Acronym
BBLURAN
Condition
Intracranial Aneurysm
Intervention (Drug)
Nebivolol
Intervention (Drug)
Placebo
Lead sponsor
Jagiellonian University (class: other)
Collaborator
University Hospital in Krakow (class: other)

Record details

Record id
cardio:ct-nct06249802
Content hash
5444875cf5ccab2b83709d9e02629ca8a236fe0c98833449f8c43c28c2023d83